期刊文献+

α-硫辛酸联合莫沙必利治疗糖尿病神经源性膀胱的临床研究 被引量:4

Clinical effect of lipoic acid combined with mosapride in the treatment of diabetic neurogenic bladder
原文传递
导出
摘要 目的 观察α-硫辛酸、莫沙必利联合治疗糖尿病神经源性膀胱的临床疗效。方法 30例2型糖尿病神经源性膀胱患者,在良好控制血糖、血脂等代谢指标的基础上,给α-硫辛酸、莫沙必利联合治疗3周,比较治疗前后膀胱残余尿量及尿动力学指标的变化。结果 治疗3周及停药4周后患者膀胱残余尿量、平均尿流率、最大尿流率、逼尿肌压力分别为(62.5±27.8)ml和(61.3±21.6)ml、(8.3±1.9)ml/s和(7.9±2.1)ml/s、(10.7±1.8)ml/s和(10.3±1.6)ml/s、(25.6±2.7)cm H2O和(24.5±2.3)cm H2O,均优于治疗前的(128.3±72.5)ml、(5.2±1.3)ml/s、(8.4±1.2)ml/s、(18.1±1.2)cm H2O(t=4.01、4.21、3.45、3.52、3.68、3.47、3.33、3.24,均P〈0.01)。结论 α-硫辛酸联合莫沙必利治疗糖尿病神经源性膀胱有较好的临床疗效。 Objective To observe the efficacy of lipoic acid combined with mosapride in the treatment of diabetic neurogenic bladder.Methods 30 patients with type 2 diabetes complicated with diabatic neurogenic bladder were treated with lipoic acid and mosapride for three weeks,on the base of good controlling of blood glucose,blood lipids,and other metabolic indicators.The residual urine volume of bladder and urodynamic indicators were compared before and after treatment.Results The residual urine volume of bladder and urodynamic indicators after treatment for three weeks and withdrawal for four weeks were (62.5±27.8)ml and (61.3±21.6)ml,(8.3±1.9)ml/s and (7.9±2.1)ml/s,(10.7±1.8)ml/s and (10.3±1.6)ml/s,(25.6±2.7)cm H2O and (24.5±2.3)cm H2O,which were significiantly better than those before treatment[(128.3±72.5)ml,(5.2±1.3)ml/s,(8.4±1.2)ml/s,(18.1±1.2)cm H2O](t=4.01,4.21,3.45,3.52,3.68,3.47,3.33,3.24,all P〈0.01).Conclusion Lipoic acid combined with mosapride has good effect in the treatment of diabetic neurogenic bladder.
出处 《中国基层医药》 CAS 2013年第11期1620-1621,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 2型糖尿病 神经 膀胱 Α-硫辛酸 莫沙必利 Type 2 diabetes Nerve Urinary bladder Lipoic acid Mosapride
  • 相关文献

参考文献11

二级参考文献17

共引文献52

同被引文献28

  • 1王述进,李俊枝,左红,周克斌,杨勇,赵留存.尿流动力学检查在糖尿病神经源性膀胱诊断中的意义[J].现代医学,2005,33(6):382-383. 被引量:6
  • 2梅花,李小飞.前列腺素E1联合硫辛酸治疗糖尿病周围神经病变疗效观察[J].中国卫生产业,2007(07X):101-101. 被引量:3
  • 3CHANG s,HYPOLITE JA, MOHANAN S, et al. Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder [ J ]. Lab Invest,2009,89(7) :823 -832.
  • 4DONN J, LEDGER A. An update on the treatment and management of diabetic peripheral neuropathy[ J ]. Cannt J ,2006,16 (4) : 32 - 38.
  • 5HEAD KA. Peripheral neuropathy: pathogenic mechanisms and alternative therapies [ J ]. Altem Med Rew, 2006,11 ( 4 ) : 294 - 329.
  • 6SEKIDO H, SUZUKI T, JOMORI T, et al. Rudueed cell replication and induction of apoptosis by advanced glycation end products in rat schwann cells [ J ]. Biodem Biophys Res Commum, 2004,320 ( 1 ) :241 -248.
  • 7Ren LM,Zhuo YJ,Hao ZS, et al.Berberine improves neuro- genic contractile response of bladder detrusor muscle in streptozotocin -induced diabetic rats [J].Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs,2013,150(3): 1128-1136.
  • 8Gabriella Deli,Edit Bosnyak,Gabriella Pusch, et al.Diabetic neuropathies: diagnosis and management[J].Neuroendocrinol- ogy: International Journal for Basic and Clinical Studies on Neuroendocrine Relationships,2013,98(4):267-280.
  • 9井永敏,丁俊琴,曹志坤,郭玉红,康云霞,马惠敏.个体化护理对脊髓损伤患者神经源性膀胱康复的影响[J].护士进修杂志,2010,25(10):923-924. 被引量:39
  • 10李华,滕茂蓉.依帕司他联合莫沙必利治疗糖尿病神经源性膀胱临床观察[J].医学临床研究,2010,27(10):1809-1810. 被引量:12

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部